Biogen Inc (BIIB) Sec Form 8K
Biogen Inc (NASDAQ: BIIB) Sec Form 8K
Biogen Inc (BIIB) Biogen Announces Board Chair Transition
Biogen Inc (NASDAQ: BIIB) FY 2026 Management Update
Biogen Inc (BIIB) Sec Form 10K
Biogen Inc (NASDAQ: BIIB) Sec Form 10K
Biogen Inc (BIIB) Sec Form 8K
Biogen Inc (NASDAQ: BIIB) Sec Form 8K
Analysis
Biogen Shares Rise on Q4 Earnings Beat Despite Lower Revenue Outlook
Shares of Biogen Inc (BIIB) rose 8.53% to $201.18 at close on Friday following the release of fourth-quarter and full-year...
AlphaGraphs
Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7%
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower revenues and adjusted earnings for the fourth quarter of fiscal 2025. The...
Biogen Inc (BIIB) Q4 2025 Earnings Call
Biogen Inc (NASDAQ: BIIB) Q4 2025 Earnings Conference
Biogen Inc (BIIB) Q4 2025 Earnings Call Transcript
Biogen Inc (NASDAQ: BIIB) Q4 2025 Earnings Call dated Feb. 12, 2025 Corporate Participants: Tim Power — Head of Investor Relations Christopher A. Viehbacher —…
Biogen Inc (BIIB) Q2 2025 Earnings Call Transcript
Biogen Inc (NASDAQ: BIIB) Q2 2025 Earnings Call dated Jul. 31, 2025 Corporate Participants: Tim Power — Head of Investor Relations Christopher A. Viehbacher —…
Biogen Inc (BIIB) Q3 2025 Earnings Call Transcript
Biogen Inc (NASDAQ: BIIB) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Tim Power — Head of Investor Relations Christopher Viehbacher — President…